Business Description
![IntelliPharmaCeutics International Inc IntelliPharmaCeutics International Inc logo](https://static.gurufocus.com/logos/0C000009H4.png?14)
IntelliPharmaCeutics International Inc
NAICS : 325412
SIC : 3741
ISIN : CA4581731011
Compare
Compare
Traded in other countries / regions
IPCI.H.CanadaIPCIF.USAI4AA.Germany IPO Date
2013-11-22Description
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -8.22 | |||||
Debt-to-Equity | -0.17 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -111.84 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -75.9 | |||||
3-Year EBITDA Growth Rate | 40 | |||||
3-Year EPS without NRI Growth Rate | 35.8 | |||||
3-Year FCF Growth Rate | 48.5 | |||||
3-Year Book Growth Rate | -24.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 47.33 | |||||
6-1 Month Momentum % | -1.11 | |||||
12-1 Month Momentum % | -25.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.06 | |||||
Cash Ratio | 0.03 | |||||
Days Sales Outstanding | 73.44 | |||||
Days Payable | 78681.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.4 | |||||
Shareholder Yield % | -18.68 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 98.03 | |||||
Operating Margin % | -279.12 | |||||
Net Margin % | -350.12 | |||||
FCF Margin % | 11.81 | |||||
ROA % | -205.83 | |||||
ROIC % | -77.92 | |||||
ROC (Joel Greenblatt) % | -349.02 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.16 | |||||
Price-to-Free-Cash-Flow | 11.43 | |||||
Price-to-Operating-Cash-Flow | 11.43 | |||||
EV-to-EBIT | -1.32 | |||||
EV-to-EBITDA | -1.4 | |||||
EV-to-Revenue | 4.2 | |||||
EV-to-FCF | 31.24 | |||||
Price-to-Median-PS-Value | 0.32 | |||||
Earnings Yield (Greenblatt) % | -75.76 | |||||
FCF Yield % | 6.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IntelliPharmaCeutics International Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.838 | ||
EPS (TTM) (€) | -0.086 | ||
Beta | 3.29 | ||
Volatility % | 74.82 | ||
14-Day RSI | 47.33 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 0.0445 | ||
12-1 Month Momentum % | -25.83 | ||
52-Week Range (€) | 0.0345 - 0.0775 | ||
Shares Outstanding (Mil) | 33.09 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IntelliPharmaCeutics International Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IntelliPharmaCeutics International Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
IntelliPharmaCeutics International Inc Frequently Asked Questions
What is IntelliPharmaCeutics International Inc(FRA:I4AA)'s stock price today?
The current price of FRA:I4AA is €0.04. The 52 week high of FRA:I4AA is €0.08 and 52 week low is €0.03.
When is next earnings date of IntelliPharmaCeutics International Inc(FRA:I4AA)?
The next earnings date of IntelliPharmaCeutics International Inc(FRA:I4AA) is .
Does IntelliPharmaCeutics International Inc(FRA:I4AA) pay dividends? If so, how much?
IntelliPharmaCeutics International Inc(FRA:I4AA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |